Evidence map›Paper›PMID 28467017›Full record

ArticleJournal of cellular and molecular medicine2017

Peripheral blood aspirates overexpressing IGF-I via rAAV gene transfer undergo enhanced chondrogenic differentiation processes.

Janina Frisch, Patrick Orth, Ana Rey-Rico, Jagadeesh Kumar Venkatesan, Gertrud Schmitt, Henning Madry, Dieter Kohn, Magali Cucchiarini

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Janina FrischCenter of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany.
Patrick OrthCenter of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany.
Ana Rey-RicoCenter of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany.
Jagadeesh Kumar VenkatesanCenter of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany.
Gertrud SchmittCenter of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany.
Henning MadryCenter of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany.
Dieter KohnDepartment of Orthopaedic Surgery, Saarland University Medical Center, Homburg/Saar, Germany.
Magali CucchiariniCenter of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany.ORCID http://orcid.org/0000-0003-0323-8922
Saarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Implantation of peripheral blood aspirates induced towards chondrogenic differentiation upon genetic modification in sites of articular cartilage injury may represent a powerful strategy to enhance cartilage repair. Such a single-step approach may be less invasive than procedures based on the use of isolated or concentrated MSCs, simplifying translational protocols in patients. In this study, we provide evidence showing the feasibility of overexpressing the mitogenic and pro-anabolic insulin-like growth factor I (IGF-I) in human peripheral blood aspirates via rAAV-mediated gene transfer, leading to enhanced proliferative and chondrogenic differentiation (proteoglycans, type-II collagen, SOX9) activities in the samples relative to control (reporter rAAV-lacZ) treatment over extended periods of time (at least 21 days, the longest time-point evaluated). Interestingly, IGF-I gene transfer also triggered hypertrophic, osteo- and adipogenic differentiation processes in the aspirates, suggesting that careful regulation of IGF-I expression may be necessary to contain these events in vivo. Still, the current results demonstrate the potential of targeting human peripheral blood aspirates via therapeutic rAAV transduction as a novel, convenient tool to treat articular cartilage injuries.

Indexed as

BiomarkersCell- and Tissue-Based TherapyCell DifferentiationCell ProliferationChondrocytesChondrogenesisCollagen Type IIDependovirusGene ExpressionGenetic VectorsHumansInsulin-Like Growth Factor ILac OperonMesenchymal Stem CellsPrimary Cell CultureProteoglycansBiomarkersCollagen Type IIInsulin-Like Growth Factor IProteoglycansSOX9 protein, humanSOX9 Transcription Factorcartilage repairgene therapyIGF-Iperipheral bloodrAAV vectors

Identifiers

PMID28467017
PMCPMC5661259
OpenAlexW2611033217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.